[1] Howard M.Interleukins for B lymphocytes[J].Survey of Immunologic Research,1983,2(3):210-212.
[2] Scott T R,Lillehoj H S. Monoclonal antibodies against chicken interleukin-6[J]. Veterinary Immunology and Immunopathology,2006,114(1-2):173-177.
[3] Lillehoj H S,Min W,Sohn E J,et al. Development and characterization of monoclonal antibodies to chicken interleukin-15[J].Veterinary Immunology and Immunopathology,2002,88:49-56.
[4] 李睿.白细胞介素-4的研究进展[J]. 华北煤炭医学院学报,2011,13(3):329-332.
[5] Lee S W,Hong Y S,Chun C M,et al. Anti-inflammatory effects of IL-4 and IL-10 on human polymorpho nuclear leukocytes[J].J Korean Med Sci,2002,17(1):7-14.
[6] Eijkelkamp N, Steen-Louws C,Hartgring S A,et al.IL4-10 fusion protein is a novel drug to treat persistent inflammatory pain[J].The Journal of Neuroscience,2016,36(28):7353-7363.
[7] 陈国华,景志忠,窦永喜,等.猪白细胞介素-4重组蛋白的纯化及其生物学特性分析[J].畜牧兽医学报,2007, 38(10):1072-1076.
[8] 叶丽萍.细胞因子在抗鸡球虫病中的作用机制及应用的研究进展[J].中国畜牧兽医,2014,41(12):250-253.
[9] Kouwenhoven M,Ozenci V,Teleshova N,et al. Enzyme-linked immunospot assays provide a sensitive tool for detection of cytokine secretion by monocytes[J].Clinical and Diagnostic Laboratory Immunology, 2001,8(6):1248-1257.
[10] Yousefi A,Mahmoudi E,Zare Bidoki A,et al. IL-4 gene polymorphisms in Iranian patients with autoimmune hepatitis[J].Expert Review of Gastroenterology & Hepatology,2016,10(5):659-663.
[11] Van Dyken S J,Locksley R M. Interleukin-4- and interleukin-13-mediated alternatively activated macrophages:Roles in homeostasis and disease[J].Annual Review of Immunology,2013,31:317-343.
[12] Ziaee V,Rezaei A,Harsini S,et al. Polymorphisms of genes encoding interleukin-4 and its receptor in Iranian patients with juvenile idiopathic arthritis[J]. Clinical Rheumatology,2016,35(8):1943-1948.
[13] Vijayanand P,Seumois G,Simpson L,et al. Interleukin-4 production by follicular helper T cells requires the conserved IL-4,enhancer hypersensitivity site V[J].Immunity,2012,36(2):175-187.
[14] Skaria T,Burgener J,Bachli E,et al. IL-4 causes hyperpermeability of vascular endothelial cells through Wnt5A signaling[J]. PLoS One,2016,11(5):e0156002.
[15] Paul W E. History of interleukin-4[J].Cytokine,2015,75(1):3-7.
[16] Ishii K J,Weiss W R,Ichino M,et al.Activity and safety of DNA plasmids encoding IL-4 and IFN gamma[J]. Gene Therapy,1999,6(2):237-244.
[17] Song K,Chang Y,Prud' homme G J. Regulation of Thelper-1 versus T-helper-2 activity and enhancement of tumor immunity by combined DNA-based vaccination and nonviral cytokine gene transfer[J].Gene Therapy,2000,7(6):481-492.
[18] Hartgring S A,Steenslouws C, Smet M D,et al. IL-4-10 synerkine:A novel anti-inflammatory drug to inhibit immunopathology in rheumatic diseases[J].Annals of the Rheumatic Diseases,2014, 72(S3):A371.
[19] Li Z,Wang G,Wang Y,et al. Rescue and evaluation of a recombinant PRRSV expressing porcine Interleukin-4[J].Virology Journal,2015,41(12):185. |